Pharming announces the placement of €125 million senior unsecured convertible bonds due 2025
Financial updatesPharming Group N.V. announces today the placement of €125 million of senior unsecured convertible bonds due 2025 (the “Bonds”). The offer was fully subscribed. The Bonds were offered via an accelerated book building process through a private placement only to institutional investors outside the United States of America, Australia, South Africa, and Japan.